Skip to content

CRISPR-edited Knockout iPS Cells

Accelerate disease model development, drug discovery, and regenerative medicine with the high editing efficiency and precise genomic integration of EditCo's edited iPS Cells.

Let's talk about how our iPS Cells can help your research.
Contact Us
Overview

Accurate, efficient models for advanced disease research.

  • Quality: iPSC quality, pluripotency, and cell integrity are maintained through EditCo’s editing process.
  • Unparalleled Editing Efficiency: Our automated, optimized platform and superior quality reagents result in high-efficiency editing.
  • High Success Rates: EditCo’s robust CRISPR editing process consistently delivers functional gene knockouts.
iPS Cells

Experience Unmatched CRISPR Knockout Efficiency in iPSCs

Discover the one-stop solution for reliable and precise knockouts in induced pluripotent stem cells (iPSCs) with EditCo's Engineered Knockout iPS Cells. Our advanced CRISPR editing technology ensures consistently high knockout efficiency (>95%), achieving near-complete functional knockouts even before clonal selection. Utilizing high-quality synthetic non-integrating reagents, our proprietary automated process maintains cell viability and pluripotency, ensuring your cells are artifact-free and your experimental integrity remains intact. Choose EditCo’s Engineered Knockout iPS Cells, available as 100% knockout guaranteed clones or as efficient, non-sorted pools, to elevate your gene function and disease linkage studies. Unlock unprecedented potential and accelerate your research with EditCo.

EditCo’s Automated iPS Cell Line Editing Process

Cell Pools Clones Timeline

 

Gene Function
Gene Function Studies: Functionally disrupt your target gene to confirm if it is necessary for a specific phenotype or cellular function.
Gene-Disease
Gene-Disease Linkage: Investigate the genetic factors involved in the pathogenesis of neurodegenerative diseases with edited iPSCs differentiated into a neuronal cell type of interest.
Pathway Analysis
Pathway Analysis: Systemically knockout genes in your disease pathway and differentiate cells into disease-relevant cell types to assay to identify ideal drug targets.
Target Validation
Target Validation: Validate your identified targets in CRISPR-edited iPSCs to confirm gene-disease linkage in biologically relevant cell models.
Single-guide RNA Knockout Cell Pools

Single-guide RNA Knockout Cell Pools

Pre-clonal iPSC CRISPR KO Cells: Your Unique Assay Validation Tool

EditCo’s Knockout iPS Cell Pools offer a heterogeneous population of induced pluripotent stem cells. Each pool contains iPSCs edited to knock out your gene of interest through CRISPR transfection and a population of unedited cells. Delivered prior to clonal isolation, these pools combine the benefits of EditCo’s optimized CRISPR editing process with high knockout efficiency. For a homogeneous cell population ready for immediate use, explore our Knockout iPS Cell Clones with automated clonal isolation.

Features

Cell Source

  • EditCo supplied (standard)
  • Customer supplied

Available Edits

  • Indel (standard) or fragment deletion
  • A heterogeneous population of edited and unedited cells

CRISPR Design

  • Synthetic modified sgRNA (standard)
  • Multiple synthetic modified sgRNAs

Add-Ons 

  • QC: Pluripotency testing

Deliverables

  • Regular updates on your order's progress
  • Edited cell pools (2 vials with 5x10⁵ cells/vial)
  • Mock-transfected cell pools (2 vials with 5x10⁵ cells/vial)
  • Sequence of synthetic sgRNA used
  • Primer sequences used for NGS sequencing
  • NGS sequencing analysis report for each edited pool after expansion. 
  • Comprehensive QC report that includes the following information: mycoplasma test (positive/negative), passage number, and analysis for add-on QC

Sequencing deliverable note: For large fragment deletions and non-human/mouse cell types, an alignment between the Sanger sequencing data of the edited clone and the reference will be provided

Unprecedented Knockout Editing Efficiency

EditCo’s Knockout iPS Cells deliver reliable protein knockout enabling your gene function studies.

iPSC_ko_1

Figure 1. Modified gRNAs were transfected along with Cas9 as RNPs to knock out RELA in four individual iPS cell lines. Each population of cells was PCR-amplified around the cut site, Sanger-sequenced, and submitted for ICE analysis to determine editing efficiency.

 

Validate your Assays with up to 95% Protein Knockout

EditCo’s Knockout Cell Pool gives you the protein knockout you need in the cell line you want, enabling you to either assay pools directly or quickly move to isolate single cell clones.

Gene Protein KO

Figure 2. EditCo’s Knockout Cell Pool achieved 95% protein knockout without clonal expansion. A cell pool with a surface protein knocked out was generated in U2OS cells with a Knockout Score of 87% (left panel, which is the percentage of indels that either introduce a frameshift mutation or are larger than 21 nucleotides, analyzed by ICE). Levels of this protein were analyzed by flow cytometry (blue) and were reduced by 95% relative to wild type (green, right panel). Negative control samples were stained with an isotype control antibody (purple). Data provided by Eurofins-DiscoverX.

Single-guide RNA Knockout Cell Clones

Single-guide RNA Knockout Cell Clones

Guaranteed iPSC CRISPR Knockout, Ready for Downstream Applications

EditCo’s Knockout iPS Cell Clones offer a homogeneous population of induced pluripotent stem cells with your desired protein functionally knocked out, guaranteed. These clones are the simplest way to harness the power of CRISPR in your lab, enabling you to focus on your research and downstream applications with confidence.

Features

Cell Source

  • EditCo supplied (standard)
  • Customer supplied

Available Edits

  • Indel (standard) or fragment deletion
  • Homozygous (standard) or heterozygous edits

CRISPR Design

  • Synthetic modified sgRNA (standard)
  • Multiple synthetic modified sgRNAs

Add-Ons

  • Additional clones
  • QC: Pluripotency Testing
  • QC: Karyotype Testing

Deliverables

  • Regular updates on your order's progress
  • 2 independent clones with the required knockout (2 vials of each clone with 5x10⁵ cells/vial)
  • Mock-transfected cell pools (2 vials with 5x10⁵ cells/vial)
  • Sequence of synthetic sgRNA used
  • Primer sequences used for NGS sequencing
  • NGS sequencing analysis report for each edited pool after expansion.
  • Comprehensive QC report that includes the following information: mycoplasma test (positive/negative), passage number, and analysis for add-on QC

Sequencing deliverable note: For large fragment deletions and non-human/mouse cell types, an alignment between the Sanger sequencing data of the edited clone and the reference will be provided

EditCo Delivers Pluripotent Edited Cell Clones

EditCo’s CRISPR Knockout Cell Clones eliminate the time and hassle of doing CRISPR editing and creating clonal cell lines so you can focus on your research.

iPSC1

Figure 3. iPS cells were assessed for standard pluripotency markers, three days post-editing.

Cell Lines

Use Our iPS Cell Lines or Onboard Your Own

 
EditCo-supplied cell lines available for all engineered iPS cell orders at no additional cost

EditCo iPS Cells

* Parental vials available for evaluation prior to booking an edit

Resources

Article
A New Research Toolbox at the Forefront of Genomic Engineering
This GEN article describes how EditCo’s novel CRISPR platform is changing cell and gene therapy research, including high-throughput iPSC editing.
Learn More
Application Note
CRISPR-Engineered Cells Enable Variant Disease Modeling
Understand how all researchers can leverage CRISPR-engineered cells to model multiple genetic variants and clones at scale.
Learn More
Flyer
CRISPR-Edited iPS Cells, Guaranteed
We offer knockouts, single nucleotide variants, and tag insertions in control or patient-derived iPS cell lines—available in homozygous or heterozygous clone or pool formats.
Learn More
EditCo's Automated CRISPR Platform

Integrating our core CRISPR expertise, high-quality reagents, and automated processes, we deliver the best edited cell-based models at any scale.

CRISPR Engineered Cells Enable Variant Disease Modeling
Icon_Pools_Trans
Leveraging a sophisticated infrastructure with integration between bioinformatics, software, and automated platforms
Learn More
Icon_TCell_Trans
Automating biology and synergistic disciplines for streamlined cell editing and cell culture workflows
Learn More
Icon_iPSC_Trans
Delivering experiment-ready edited cells for your next discoveries through a robust and cohesive ecosystem
Learn More
Lorem Overline

Testimonials consectitur amet sed

Lorem Button Text
Congue fermentum eros leo commodo. Integer vitae vitae ac amet. Vitae sed lectus vel lacus adipiscing nulla facilisis mauris porttitor. Viverra elementum odio vitae id.
placeholder-56x56
Albert Rose, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Viverra aliquam volutpat interdum quisque vel mattis. Malesuada aliquam egestas pharetra a tempus ullamcorper egestas.
placeholder-56x56
Amanda Peyton, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute
Nibh luctus pulvinar sagittis faucibus commodo vitae purus. Ullamcorper dictum.
placeholder-56x56
Joseph James, Ph. D.
Principal Investigator, Boston Children's Hospital
Congue fermentum eros leo commodo. Integer vitae vitae ac amet. Vitae sed lectus vel lacus adipiscing nulla facilisis mauris porttitor. Viverra elementum odio vitae id.
placeholder-56x56
Albert Rose, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Congue fermentum eros leo commodo. Integer vitae vitae ac amet. Vitae sed lectus vel lacus adipiscing nulla facilisis mauris porttitor. Viverra elementum odio vitae id.
placeholder-56x56
Albert Rose, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Congue fermentum eros leo commodo. Integer vitae vitae ac amet. Vitae sed lectus vel lacus adipiscing nulla facilisis mauris porttitor. Viverra elementum odio vitae id.
placeholder-56x56
Albert Rose, Ph. D.
Principal Investigator, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Lorem Button Text

Lectus Pluristyx eu vel leo lectus mi. Viverra cursus neque eget proin.

Pellentesque nec tempus ultrices purus amet adipiscing aliquam. Posuere imperdiet adipiscing non blandit non. Sed eros vel sodales magna sem tincidunt orci risus. Molestie hendrerit cursus faucibus ac neque eget turpis. Arcu leo risus iaculis mi. Tortor bibendum sed cras pretium leo.

0+

Edits Performed

0+

Edits Performed

0+

Edits Performed
Lorem Overline

Lorem Ipsum Dolor Heading

Etiam sollicitudin, ipsum eu pulvinar rutrum, tellus ipsum laoreet sapien, quis venenatis ante odio sit amet eros. Duis arcu tortor, suscipit eget, imperdiet nec, imperdiet iaculis, ipsum. Maecenas nec odio et ante tincidunt tempus. Donec elit libero, sodales nec, volutpat a, suscipit non, turpis. Quisque id mi.

Lorem Button Text
Lorem Overline

Resources aliquam procte

Lorem Button Text
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
placeholder-280x160
Lorem overline
Ultrices nullam dictumst erat molestie massa a amet pulvinar bibendum lacus.
Tortor consectetur viverra malesuada dignissim duis quis. Morbi purus in velit lacus diam odio sed. Sed nisl arcu amet ut.
Read More
Lorem Button Text

Reach out to our experts to find out what EditCo can do for you